Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Best AOD-9604 Dosage Cartilage Repair 2026: Protocol Comparison

Before selecting a dosing protocol, researchers must understand that cartilage repair timelines differ fundamentally from metabolic endpoints. Fat loss from AOD-9604 is measurable within 4–6 weeks, but cartilage matrix synthesis requires 8–12 weeks minimum to

This comparison does not assign a generated winner or score.

  • Before selecting a dosing protocol, researchers must understand that cartilage repair timelines differ fundamentally from metabolic endpoints. Fat loss from AOD-9604 is measurable within 4–6 weeks, but cartilage matrix synthesis requires 8–12 weeks minimum to produce histologically detectable changes.
  • Metabolic/Lipolytic Standard
  • 200mcg
  • Once daily
  • Not applicable
  • 4–6 weeks for fat loss
  • Underdosed for cartilage. Designed for different endpoint
  • Low-Range Cartilage Protocol
  • 300mcg
  • Twice daily (150mcg each)
  • 60–90 min pre-exercise
  • 8–12 weeks for measurable preservation
  • Minimum effective dose. Works in early-stage damage only
  • Optimal Cartilage Protocol
  • 400–500mcg
  • Twice daily (200–250mcg each)
  • Current research standard. Balances efficacy and safety margin
  • High-Dose Exploratory
  • 600mcg+
  • Twice daily (300mcg+ each)
  • Unknown. Limited data above 500mcg
  • Not recommended. No evidence of added benefit, potential for off-target effects
  • The optimal cartilage protocol (400–500mcg split twice daily) represents the current consensus based on preclinical models and limited human pilot data. Doses below 300mcg showed inconsistent chondrocyte proliferation in in vitro assays, while doses above 600mcg did not produce proportionally greater matrix synthesis and raised theoretical concerns about systemic IGF-1 pathway activation. Though no adverse metabolic effects have been documented even at 1mg daily in short-term obesity trials.
More references

Related material